Document is current
Any future updates will be listed below
-
Authors
Sadybekov, Anastasiia V.
Duro, Marlon Vincent
Wang, Shaowei
Ebright, Brandon
Dikeman, Dante
Hugo, Cristelle
Kerman, Bilal Ersen
Ma, Qiu-Lan
Nazarova, Antonina L.
Sadybekov, Arman A.
Asante, Isaac
Louie, Stan G.
Katritch, Vsevolod
Yassine, Hussein N.
-
Funding
Funding for this research was provided by:
National Institute on Aging (U01AG094622)
National Institute on Aging (U01AG094622)
National Institute on Aging (U01AG094622)
National Institute of General Medical Sciences (R01GM147537)
- License Information
-
More Information
Article History
Received: 23 March 2025
Accepted: 20 November 2025
First Online: 7 January 2026
Competing interests
: HNY is the founder of PeBRx, which is developing cPLA 2 inhibitors. No other authors have any competing interests.
